Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record and indicating that access to the entry is blocked.
    Difference
    0.5%
    Check dated 2026-09-27T04:00:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    403 Forbidden error page is now shown, with a minimal header, replacing the study record content and navigation. This indicates an access restriction rather than an update to the core study information.
    Difference
    22%
    Check dated 2026-09-20T02:08:02.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.6.6 from v3.6.5. This marks a minor site update and does not modify the study data or page content.
    Difference
    0.0%
    Check dated 2026-08-30T00:38:53.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, signaling a minor version update rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-08-08T23:21:23.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added (replacing v3.6.3), reflecting an administrative update to the page.
    Difference
    0.0%
    Check dated 2026-07-25T18:17:24.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.3, replacing the previous v3.6.2; this indicates a minor page version update to the study record.
    Difference
    0.0%
    Check dated 2026-07-04T13:23:37.000Z thumbnail image

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.